It is currently classified as a research peptide and has not been evaluated by the FDA for safety or efficacy in humans
BPC-157, also known as Body Protection Compound-157, is a pentadecapeptide (a 15-amino acid peptide sequence) first described in 1992
Moreover, radical-scavenging antioxidants such as Astragenol, Acteoside, and Edaravone have demonstrated neuroprotective effects in NDDs, primarily by neutralizing ROS, promoting GSH synthesis, and maintaining GPX4 activity to alleviate neuronal ferroptosis (Xiao et al., 2025
Schedule a consultation with Formation in Tampa by calling (813) 922-2920
Final Thoughts & Caution Compounded Semaglutide / Cyanocobalamin Injection is an intriguing, patient-tailored option that may offer metabolic plus micronutrient support in one shot
Oral peptides bypass the injection entirely but may have different bioavailability and primary effects compared to their injectable counterparts